Chemours Co (CC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 2.5B 5B 7.5B Q3 '21: 6.1B Q4 '21: 6.3B Q1 '22: 6.7B Q2 '22: 6.9B Q3 '22: 7B Q4 '22: 6.8B Q1 '23: 6.6B Q2 '23: 6.3B Q3 '23: 6B Q4 '23: 6B Q1 '24: 5.9B Q2 '24: 5.8B Q3 '24: 5.8B Q4 '24: 5.8B Q1 '25: 5.8B Q2 '25: 5.8B Q3 '25: 5.8B Q4 '25: 5.8B Q1 '26: 5.8B Q2 '26: 5.8B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 700M 1.4B 2.1B Q3 '21: 1.3B Q4 '21: 1.4B Q1 '22: 1.6B Q2 '22: 1.8B Q3 '22: 1.8B Q4 '22: 1.6B Q1 '23: 1.5B Q2 '23: 1.4B Q3 '23: 1.3B Q4 '23: 1.3B Q1 '24: 1.2B Q2 '24: 1.1B Q3 '24: 1.1B Q4 '24: 1.1B Q1 '25: 1.1B Q2 '25: 1.1B Q3 '25: 1B Q4 '25: 903M Q1 '26: 879M Q2 '26: 887M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Net Income TTM

-700M -350M 0 350M 700M 1.1B Q3 '21: 395M Q4 '21: 609M Q1 '22: 747M Q2 '22: 882M Q3 '22: 908M Q4 '22: 578M Q1 '23: 489M Q2 '23: -88M Q3 '23: -316M Q4 '23: -237M Q1 '24: -328M Q2 '24: 108M Q3 '24: 64M Q4 '24: 71M Q1 '25: 12M Q2 '25: -428M Q3 '25: -336M Q4 '25: -372M Q1 '26: -396M Q2 '26: -290M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 2B 4B 6B Q3 '21: 4.8B Q4 '21: 5B Q1 '22: 5.1B Q2 '22: 5.1B Q3 '22: 5.2B Q4 '22: 5.2B Q1 '23: 5.1B Q2 '23: 4.9B Q3 '23: 4.8B Q4 '23: 4.7B Q1 '24: 4.6B Q2 '24: 4.7B Q3 '24: 4.7B Q4 '24: 4.6B Q1 '25: 4.7B Q2 '25: 4.8B Q3 '25: 4.8B Q4 '25: 4.9B Q1 '26: 4.9B Q2 '26: 4.9B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-700M -350M 0 350M 700M 1.1B Q3 '21: 959M Q4 '21: 814M Q1 '22: 777M Q2 '22: 812M Q3 '22: 802M Q4 '22: 755M Q1 '23: 629M Q2 '23: 405M Q3 '23: 235M Q4 '23: 556M Q1 '24: 390M Q2 '24: -297M Q3 '24: -289M Q4 '24: -633M Q1 '25: -455M Q2 '25: 258M Q3 '25: 265M Q4 '25: 264M Q1 '26: 332M Q2 '26: 397M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-1.1B -700M -350M 0 350M 700M 1.1B Q3 '21: 712M Q4 '21: 537M Q1 '22: 454M Q2 '22: 494M Q3 '22: 479M Q4 '22: 448M Q1 '23: 337M Q2 '23: 117M Q3 '23: -67M Q4 '23: 186M Q1 '24: 9M Q2 '24: -693M Q3 '24: -675M Q4 '24: -993M Q1 '25: -797M Q2 '25: -54M Q3 '25: -12M Q4 '25: 51M Q1 '26: 154M Q2 '26: 218M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 60M 120M 180M Q1 '20: 165.3M Q2 '20: 165.4M Q3 '20: 166.6M Q1 '21: 169.1M Q2 '21: 170.2M Q3 '21: 169M Q1 '22: 163.6M Q2 '22: 159.7M Q3 '22: 157.9M Q1 '23: 151.2M Q2 '23: 149.1M Q3 '23: 150.2M Q1 '24: 150.1M Q2 '24: 150.1M Q3 '24: 149.7M Q1 '25: 149.9M Q2 '25: 150.2M Q3 '25: 150.8M Q1 '26: 150.8M Q2 '26: 151.2M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.00 -2.00 0.00 2.00 4.00 6.00 Q3 '21: 2.34 Q4 '21: 3.62 Q1 '22: 4.48 Q2 '22: 5.35 Q3 '22: 5.60 Q4 '22: 3.56 Q1 '23: 3.09 Q2 '23: -0.69 Q3 '23: -2.13 Q4 '23: -1.60 Q1 '24: -2.20 Q2 '24: 0.71 Q3 '24: 0.41 Q4 '24: 0.45 Q1 '25: 0.06 Q2 '25: -2.86 Q3 '25: -2.24 Q4 '25: -2.47 Q1 '26: -2.63 Q2 '26: -1.91 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.